CINCINNATI, Dec. 1, 2025 /PRNewswire/ -- Scientists at Cincinnati Children's have taken a key early step in understanding why some people born with the rare disease Adams-Oliver syndrome (AOS) ...
FRIDAY, April 25, 2025 (HealthDay News) — Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study says. Testing for these genetic ...
Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present in ...
Tapping into the Million Veteran Program, an ongoing national research effort to learn how genes, lifestyle and military exposures affect the health of participants, researchers at University of ...
A study published in the journal Non-Coding RNA describes the involvement of microRNA-205 in mammary gland development in female mice. MicroRNAs are small, highly conserved, non-coding RNA molecules ...
Nestled on the southern fringe of Cambridge within the Babraham Research Campus, US-based biopharma Insmed is laying the groundwork for its next chapter in rare disease therapeutics. Known for its ...
Scientists in the US and the UK may have found a way to treat infantile Batten disease, according to The Guardian. GATERSLEBEN, GERMANY - APRIL 22: Petri dishes containing sprouting barley embryos ...
Ideaya Biosciences uses synthetic lethality to target cancer cells and has seen its stock double since March. Synthetic lethality can selectively target cancer cells while sparing normal cells, ...
An international research team led by Justus Liebig University Giessen (JLU) and the Joint FAO/IAEA Center of Nuclear Techniques in Food and Agriculture has identified the gene responsible for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback